
Resistance-fighting antimalarial drug candidate enters the clinic
A new antimalarial drug candidate, discovered through a longstanding collaboration between WEHI and global biopharmaceutical company MSD has entered Phase 1 clinical testing in healthy participants. The candidate drug inhibits ...
Apr 6, 2023
0
2